Yes, in terms of absorption
GLP-1 injectables may be considered when you meet BMI criteria (typically 30 or higher, or 27 or higher with weight-related health conditions), you are comfortable with weekly self-injection, and your health profile does not include contraindications for GLP-1 medications
doi: 10.1172/JCI24422 65 HaeberleHATakizawaRCasolaABrasierARDieterichHJvan RooijenNet al
CLINICAL TRIAL EVIDENCE FOR GLP-1 RAs IN MASH Table 2 provides a summary of phase 2 and phase 3 studies examining GLP-1 RAs and dual or triple agonists (aiming glucagon, GIP, and GLP-1 receptors) in individuals with MASLD/MASH, where hepatic biopsies were used to evaluate liver outcomes [3,5,10,11,15,22-25,44-52]
Par ailleurs, en cas de ractions anormales de l'organisme pendant la cure, arrtez la prise et demandez l'avis de votre mdecin